(19)
(11) EP 3 204 074 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
29.11.2023 Bulletin 2023/48

(45) Mention of the grant of the patent:
25.10.2023 Bulletin 2023/43

(21) Application number: 15777960.4

(22) Date of filing: 09.10.2015
(51) International Patent Classification (IPC): 
A61M 5/20(2006.01)
 A61M 5/315(2006.01)
(52) Cooperative Patent Classification (CPC):
A61M 5/20; A61M 5/31535; A61M 5/31541; A61M 5/31553; A61M 5/3157; A61M 5/31593; A61M 2005/202; A61M 2205/581; A61M 2205/582; A61M 5/31583
(86) International application number:
PCT/EP2015/073435
(87) International publication number:
WO 2016/055629 (14.04.2016 Gazette 2016/15)

(54)

AUTOMATIC DRUG INJECTION DEVICE WITH TORSION DRIVE SPRING AND ROTATIONAL DOSE SETTING AND CORRECTION MECHANISM

AUTOMATISCHER ARZNEIMITTELINJEKTOR MIT TORSIONSFEDER UND DREHMECHANISMUS ZUM SETZEN UND KORRIGIEREN EINER DOSIS

DISPOSITIF AUTOMATIQUE D'INJECTION DE MÉDICAMENTS AVEC BARRE DE TORSION ET MÉCANISME ROTATIF POUR AJUSTER ET CORRIGER LA DOSE

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 09.10.2014 EP 14306595

(43) Date of publication of application:
16.08.2017 Bulletin 2017/33

(73) Proprietor: Sanofi
75017 Paris (FR)

(72) Inventors:
  • AVERY, Richard James Vincent
    Chipping Campden Gloucestershire GL55 6TX (GB)
  • JONES, Matthew
    Warwick Warwickshire CV34 6AU (GB)

(74) Representative: Keil & Schaafhausen Patentanwälte PartGmbB 
Friedrichstraße 2-6
60323 Frankfurt am Main
60323 Frankfurt am Main (DE)


(56) References cited: : 
WO-A2-2011/043605
US-A1- 2011 054 412
US-B2- 8 491 538
 US-A1- 2005 055 011
US-B2- 7 955 303
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).